235 related articles for article (PubMed ID: 1728249)
1. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
Hollander E; DeCaria CM; Nitescu A; Gully R; Suckow RF; Cooper TB; Gorman JM; Klein DF; Liebowitz MR
Arch Gen Psychiatry; 1992 Jan; 49(1):21-8. PubMed ID: 1728249
[TBL] [Abstract][Full Text] [Related]
2. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
Pigott TA; Zohar J; Hill JL; Bernstein SE; Grover GN; Zohar-Kadouch RC; Murphy DL
Biol Psychiatry; 1991 Mar; 29(5):418-26. PubMed ID: 2018816
[TBL] [Abstract][Full Text] [Related]
3. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
Hollander E; Cohen LJ; DeCaria C; Saoud JB; Stein DJ; Cooper TB; Islam NN; Liebowitz MR; Klein DF
Biol Psychiatry; 1993 Sep; 34(6):407-13. PubMed ID: 8218609
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
Khanna S; John JP; Reddy LP
Psychoneuroendocrinology; 2001 Feb; 26(2):209-23. PubMed ID: 11087965
[TBL] [Abstract][Full Text] [Related]
5. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.
Monteleone P; Catapano F; Tortorella A; Maj M
Neuropsychobiology; 1997; 36(1):8-12. PubMed ID: 9211437
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings.
Hollander E; Fay M; Cohen B; Campeas R; Gorman JM; Liebowitz MR
Am J Psychiatry; 1988 Aug; 145(8):1015-7. PubMed ID: 2839998
[TBL] [Abstract][Full Text] [Related]
7. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
McBride PA; DeMeo MD; Sweeney JA; Halper J; Mann JJ; Shear MK
Biol Psychiatry; 1992 Jan; 31(1):19-34. PubMed ID: 1311964
[TBL] [Abstract][Full Text] [Related]
9. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
Lucey JV; O'Keane V; Butcher G; Clare AW; Dinan TG
Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
[TBL] [Abstract][Full Text] [Related]
11. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
Lucey JV; Butcher G; Clare AW; Dinan TG
Acta Psychiatr Scand; 1993 Jun; 87(6):384-8. PubMed ID: 8356888
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls.
Zohar J; Mueller EA; Insel TR; Zohar-Kadouch RC; Murphy DL
Arch Gen Psychiatry; 1987 Nov; 44(11):946-51. PubMed ID: 3675134
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects.
Hollander E; Kwon J; Weiller F; Cohen L; Stein DJ; DeCaria C; Liebowitz M; Simeon D
Psychiatry Res; 1998 Jul; 79(3):213-7. PubMed ID: 9704868
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.
Gross-Isseroff R; Cohen R; Sasson Y; Voet H; Zohar J
Neuropsychobiology; 2004; 50(3):200-5. PubMed ID: 15365215
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.
Hadigan CM; Walsh BT; Buttinger C; Hollander E
Biol Psychiatry; 1995 Apr; 37(8):504-11. PubMed ID: 7619973
[TBL] [Abstract][Full Text] [Related]
16. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B
Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685
[TBL] [Abstract][Full Text] [Related]
17. Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results.
Broocks A; Pigott TA; Hill JL; Canter S; Grady TA; L'Heureux F; Murphy DL
Psychiatry Res; 1998 Jun; 79(1):11-20. PubMed ID: 9676822
[TBL] [Abstract][Full Text] [Related]
18. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
Monteleone P; Catapano F; Bortolotti F; Maj M
Biol Psychiatry; 1997 Aug; 42(3):175-80. PubMed ID: 9232209
[TBL] [Abstract][Full Text] [Related]
19. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
